Literature DB >> 23737167

Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.

Stephen Y Chan1, Joseph Loscalzo.   

Abstract

Hemodynamic stress in the pulmonary vessel is directly linked to the development of vascular remodeling and dysfunction, ultimately leading to pulmonary hypertension. Recently, some advances have been made in our molecular understanding of the exogenous upstream stimuli that initiate hemodynamic pertubations as well as the downstream vasoactive effectors that control these responses. However, much still remains unknown regarding how these complex signaling pathways connect in order to result in these characteristic pathophysiological changes. This chapter will describe our current understanding of and needed areas of research into the clinical, physiological, and molecular changes associated with pressure/volume overload in the pulmonary circulation.
© 2011 American Physiological Society.

Entities:  

Mesh:

Year:  2011        PMID: 23737167      PMCID: PMC3730284          DOI: 10.1002/cphy.c090004

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  184 in total

1.  The tantalizing triplet of pulmonary hypertension-BMP receptors, serotonin receptors, and angiopoietins.

Authors:  Oliver Eickelberg; Michael E Yeager; Friedrich Grimminger
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

Review 2.  Caveolae, lipid rafts, and vascular disease.

Authors:  Xiang-An Li; William V Everson; Eric J Smart
Journal:  Trends Cardiovasc Med       Date:  2005-04       Impact factor: 6.677

3.  Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.

Authors:  Paul B Yu; Hideyuki Beppu; Noriko Kawai; En Li; Kenneth D Bloch
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

4.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.

Authors:  Xudong Yang; Lu Long; Mark Southwood; Nung Rudarakanchana; Paul D Upton; Trina K Jeffery; Carl Atkinson; Hailan Chen; Richard C Trembath; Nicholas W Morrell
Journal:  Circ Res       Date:  2005-04-21       Impact factor: 17.367

6.  Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD.

Authors:  Pinar Yildiz; Huseyin Oflaz; Naci Cine; Nihan Erginel-Unaltuna; Faruk Erzengin; Veysel Yilmaz
Journal:  Respir Med       Date:  2003-12       Impact factor: 3.415

7.  Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway.

Authors:  Christopher C Sullivan; Lingling Du; Danny Chu; Augustine J Cho; Masakuni Kido; Paul L Wolf; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

8.  Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.

Authors:  Kohtaro Abe; Hiroaki Shimokawa; Keiko Morikawa; Toyokazu Uwatoku; Keiji Oi; Yasuharu Matsumoto; Tsuyoshi Hattori; Yutaka Nakashima; Kozo Kaibuchi; Katsuo Sueishi; Akira Takeshit
Journal:  Circ Res       Date:  2003-12-11       Impact factor: 17.367

9.  Oxidative stress in severe pulmonary hypertension.

Authors:  Rebecca Bowers; Carlyne Cool; Robert C Murphy; Rubin M Tuder; Matthew W Hopken; Sonia C Flores; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

10.  S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy.

Authors:  Steven Greenway; Robert Jan van Suylen; Gideon Du Marchie Sarvaas; Edwin Kwan; Noona Ambartsumian; Eugene Lukanidin; Marlene Rabinovitch
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

View more
  1 in total

1.  Quantitative 129Xe MRI detects early impairment of gas-exchange in a rat model of pulmonary hypertension.

Authors:  Rohan S Virgincar; John C Nouls; Ziyi Wang; Simone Degan; Yi Qi; Xinyu Xiong; Sudarshan Rajagopal; Bastiaan Driehuys
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.